VETERE, GUGLIELMO
 Distribuzione geografica
Continente #
EU - Europa 70
NA - Nord America 48
AS - Asia 44
AF - Africa 6
Totale 168
Nazione #
IT - Italia 62
US - Stati Uniti d'America 47
SG - Singapore 29
CN - Cina 13
CI - Costa d'Avorio 3
KE - Kenya 2
AT - Austria 1
BG - Bulgaria 1
CA - Canada 1
DE - Germania 1
FI - Finlandia 1
GB - Regno Unito 1
HK - Hong Kong 1
IN - India 1
NL - Olanda 1
PL - Polonia 1
SE - Svezia 1
SN - Senegal 1
Totale 168
Città #
Singapore 19
Boardman 11
Santa Clara 10
Florence 9
New York 6
Genoa 4
Milan 4
Palermo 4
Quanzhou 4
Shanghai 4
Abidjan 3
Cascina 3
Kent 3
Ogden 3
Pisa 3
Livorno 2
Lucca 2
Modena 2
Piacenza 2
Rome 2
Salerno 2
Turin 2
Dakar 1
Fort Worth 1
Fuzhou 1
Hyderabad 1
Los Angeles 1
Mazzin 1
Mugnano di Napoli 1
Munich 1
Naples 1
Shenzhen 1
The Hague 1
Toronto 1
Vienna 1
Warsaw 1
Totale 118
Nome #
Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial) 52
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 study 28
Bone metastases are associated with worse prognosis in patients affected by metastatic colorectal cancer treated with doublet or triplet chemotherapy plus bevacizumab: a subanalysis of the TRIBE and TRIBE2 trials 24
FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases 21
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 14
Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence 10
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies 10
Transcriptomic Signatures of MSI-High Metastatic Colorectal Cancer Predict Efficacy of Immune Checkpoint Inhibitors 8
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 7
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy 7
Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer 5
Totale 186
Categoria #
all - tutte 1.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202322 0 0 0 0 0 1 0 1 7 0 13 0
2023/202488 3 3 5 5 9 7 9 6 5 6 21 9
2024/202576 3 25 9 20 19 0 0 0 0 0 0 0
Totale 186